Plain-English translation of NCT06568640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a procedure called superselective adrenal arterial embolization for people with high blood pressure that doesn't respond well to medications. The procedure works by carefully blocking tiny blood vessels in the adrenal glands, which are small organs that produce hormones affecting blood pressure. Researchers want to see if this treatment is safe and whether it can help bring blood pressure down.
Many people with high blood pressure continue to have dangerously elevated readings even after taking three or more blood pressure medications. This study explores whether this minimally invasive procedure could offer a new option for patients whose blood pressure remains uncontrolled despite standard treatment.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo the adrenal artery embolization procedure at the hospital. After the procedure, you will return for follow-up visits over 8 weeks so the research team can monitor your blood pressure, check for any side effects, and measure how well the treatment is working. The study will track your safety and how effective the procedure is at lowering your blood pressure.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China